Pinglan Lu
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Extracellular vesicles in disease
- Circular RNAs in diseases
- RNA Interference and Gene Delivery
Papers in
-
- Extracellular vesicles in disease 3
-
- MicroRNA in disease regulation 2
- Cancer-related molecular mechanisms research 2
- Co-authors
- Xuxia Wei (7 shared papers)Haijin Lv (4 shared papers)Huimin Yi (5 shared papers)Guihua Chen (3 shared papers)Xiaomeng Yi (5 shared papers)Yuling An (4 shared papers)Xin Sui (2 shared papers)Yang Yang (1 shared paper)
- Journals
- Liver Research (2 papers)Cell Death and Disease (2 papers)Experimental Cell Research (1 paper)Advanced Science (1 paper)Renal Failure (1 paper)
- Partner nations
- China
In The Last Decade
Pinglan Lu
7 papers receiving 356 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 107
- Molecular Biology 238
- Critical Care and Intensive Care Medicine 15
- Genetics 30
- Immunology 41
Countries citing papers authored by Pinglan Lu
This map shows the geographic impact of Pinglan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pinglan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pinglan Lu more than expected).
Fields of papers citing papers by Pinglan Lu
This network shows the impact of papers produced by Pinglan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pinglan Lu. The network helps show where Pinglan Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Pinglan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 172 | |
| 2 | 2019 | 114 | |
| 3 | 2023 | 52 | |
| 4 | 2021 | 11 | |
| 5 | 2020 | 5 | |
| 6 | 2020 | 3 | |
| 7 | [Application of plasmapheresis combined with hemofiltration in the treatment of severe liver disease in middle and late pregnancy]. | 2015 | 1 |
| 8 | 2024 | 0 | |
| 9 | 2024 | 0 |
About Pinglan Lu
Pinglan Lu is a scholar working on Molecular Biology, Cancer Research, Surgery, Epidemiology and Pathology and Forensic Medicine, having authored 9 papers that have together received 358 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (3 papers), Organ Transplantation Techniques and Outcomes (2 papers), MicroRNA in disease regulation (2 papers), Autophagy in Disease and Therapy (2 papers), Cancer-related molecular mechanisms research (2 papers), Anesthesia and Neurotoxicity Research (1 paper), Neonatal Respiratory Health Research (1 paper) and Liver Disease and Transplantation (1 paper). The work is most often cited by research in Cancer Research (107 citations), Molecular Biology (238 citations), Critical Care and Intensive Care Medicine (15 citations), Genetics (30 citations) and Immunology (41 citations). Pinglan Lu has collaborated with scholars based in China. Frequent co-authors include Xuxia Wei, Haijin Lv, Huimin Yi, Guihua Chen, Xiaomeng Yi, Yuling An, Xin Sui, Yang Yang, Lijuan Li and Qí Zhāng. Their work appears in journals such as Liver Research, Cell Death and Disease, Experimental Cell Research, Advanced Science and Renal Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.